Abiraterone Acetate Trial in African American Prostate Cancer Patients

NCT01735396 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped poor accrual

Conditions

Prostate Cancer

Interventions

DRUG: Abiraterone Acetate

Sponsor

Icahn School of Medicine at Mount Sinai